{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:19:20Z","timestamp":1787930360540,"version":"build-2784847793"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Critical bleeding is a common cause of maternal mortality in obstetric patients. However, the non-obstetric factors underlying critical obstetric bleeding remain uncertain. Therefore, this study aimed to clarify the impact of chronic hypertension on obstetric hemorrhage by evaluating a nationwide administrative database in Japan. Women who gave birth between 2018 and 2022 were enrolled. The primary outcome was critical hemorrhage requiring massive red blood cell (RBC) transfusion during childbirth. In total, 354, 299 eligible women were selected from the database. The maternal mortality rate was &gt;1.0% among those who received a massive RBC transfusion (\u22654000\u2009cc), and this amount was used as the cutoff of the outcome. Critical hemorrhage was less frequent with elective Caesarean section (CS) compared with vaginal childbirth or emergent CS (odds ratio [OR], 0.38; 95% confidence interval, 0.30\u20130.47). Multiple logistic regression analysis adjusting for these obstetric risks revealed that a higher maternal age (adjusted OR [aOR] per 1 year, 1.07 [1.05\u20131.09]); oral medications with prednisolone (aOR, 2.5 [1.4\u20134.4]), anti-coagulants (aOR, 10 [5.4\u201319]), and anti-platelets (aOR, 2.9 [1.3\u20136.4]); and a prenatal history of hypertension (aOR, 2.5 [1.5\u20134.4]) and hypoproteinemia (aOR, 5.8 [1.7\u201320]) are the risks underlying critical obstetric hemorrhage. Prenatal history of hypertension was significantly associated with obstetric disseminated intravascular coagulation (OR, 1.9 [1.5\u20132.4]); Hemolysis, Elevated Liver enzymes, and Low platelet count (HELLP) syndrome (OR, 3.3 [2.7\u20134.2]); and eclampsia (OR, 6.1 [4.6\u20138.1]). In conclusion, a maternal prenatal history of hypertension is associated with the development of HELLP syndrome, eclampsia, and resultant critical hemorrhage.<\/jats:p>","DOI":"10.1038\/s41440-023-01511-8","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T09:09:50Z","timestamp":1700644190000},"page":"455-466","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prenatal hypertension as the risk of eclampsia, HELLP syndrome, and critical obstetric hemorrhage"],"prefix":"10.1038","volume":"47","author":[{"given":"Tetsuya","family":"Akaishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Tarasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Iwama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasumi","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Akaishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Yaegashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,22]]},"reference":[{"key":"1511_CR1","doi-asserted-by":"publisher","first-page":"e12656","DOI":"10.1002\/rth2.12656","volume":"6","author":"AH James","year":"2022","unstructured":"James AH, Federspiel JJ, Ahmadzia HK. Disparities in obstetric hemorrhage outcomes. Res Pract Thromb Haemost. 2022;6:e12656.","journal-title":"Res Pract Thromb Haemost"},{"key":"1511_CR2","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1016\/S2214-109X(13)70059-7","volume":"1","author":"F Bustreo","year":"2013","unstructured":"Bustreo F, Say L, Koblinsky M, Pullum TW, Temmerman M, Pablos-M\u00e9ndez A. Ending preventable maternal deaths: the time is now. Lancet Glob Health. 2013;1:e176\u2013177.","journal-title":"Lancet Glob Health"},{"key":"1511_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47378-z","volume":"9","author":"J Hasegawa","year":"2019","unstructured":"Hasegawa J, Katsuragi S, Tanaka H, Kurasaki A, Nakamura M, Murakoshi T, et al. Decline in maternal death due to obstetric haemorrhage between 2010 and 2017 in Japan. Sci Rep. 2019;9:11026.","journal-title":"Sci Rep."},{"key":"1511_CR4","first-page":"14","volume":"60","author":"K Irita","year":"2011","unstructured":"Irita K, Inada E. [Guidelines for management of critical bleeding in obstetrics]. Masui. 2011;60:14\u201322.","journal-title":"Masui."},{"key":"1511_CR5","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/jog.13417","volume":"43","author":"S Takeda","year":"2017","unstructured":"Takeda S, Makino S, Takeda J, Kanayama N, Kubo T, Nakai A, et al. Japanese clinical practice guide for critical obstetrical hemorrhage (2017 revision). J Obstet Gynaecol Res. 2017;43:1517\u201321.","journal-title":"J Obstet Gynaecol Res"},{"key":"1511_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-022-04824-7","volume":"22","author":"A Ueda","year":"2022","unstructured":"Ueda A, Nakakita B, Chigusa Y, Mogami H, Ohtera S, Kato G, et al. Impact of efforts to prevent maternal deaths due to obstetric hemorrhage on trends in epidemiology and management of severe postpartum hemorrhage in Japan: a nationwide retrospective study. BMC Pregnancy Childbirth. 2022;22:496.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1511_CR7","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1111\/aogs.13626","volume":"98","author":"HL Nathan","year":"2019","unstructured":"Nathan HL, Seed PT, Hezelgrave NL, De Greeff A, Lawley E, Anthony J, et al. Shock index thresholds to predict adverse outcomes in maternal hemorrhage and sepsis: a prospective cohort study. Acta Obstet Gynecol Scand. 2019;98:1178\u201386.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1511_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/1742-6723.12232","volume":"26","author":"A Olaussen","year":"2014","unstructured":"Olaussen A, Blackburn T, Mitra B, Fitzgerald M. Review article: shock index for prediction of critical bleeding post-trauma: a systematic review. Emerg Med Australas. 2014;26:223\u20138.","journal-title":"Emerg Med Australas"},{"key":"1511_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.medin.2016.02.010","volume":"40","author":"E Guasch","year":"2016","unstructured":"Guasch E, Gilsanz F. Massive obstetric hemorrhage: current approach to management. Med Intensiv. 2016;40:298\u2013310.","journal-title":"Med Intensiv"},{"key":"1511_CR10","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/jmwh.12186","volume":"59","author":"MN Schorn","year":"2014","unstructured":"Schorn MN, Phillippi JC. Volume replacement following severe postpartum hemorrhage. J Midwifery Women\u00e2\u20ac\u2122s Health. 2014;59:336\u201343.","journal-title":"J Midwifery Women\u00e2\u20ac\u2122s Health"},{"key":"1511_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-021-03853-y","volume":"21","author":"SF Bell","year":"2021","unstructured":"Bell SF, Collis RE, Pallmann P, Bailey C, James K, John M, et al. Reduction in massive postpartum haemorrhage and red blood cell transfusion during a national quality improvement project, obstetric bleeding strategy for Wales, OBS Cymru: an observational study. BMC Pregnancy Childbirth. 2021;21:377.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1511_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4103\/2229-5151.109422","volume":"3","author":"C Thongrong","year":"2013","unstructured":"Thongrong C, Kasemsiri P, Hofmann JP, Bergese SD, Papadimos TJ, Gracias VH, et al. Amniotic fluid embolism. Int J Crit Illn Inj Sci. 2013;3:51\u201357.","journal-title":"Int J Crit Illn Inj Sci"},{"key":"1511_CR13","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0749-0704(18)30286-0","volume":"7","author":"SL Clark","year":"1991","unstructured":"Clark SL. Amniotic fluid embolism. Crit Care Clin. 1991;7:877\u201382.","journal-title":"Crit Care Clin"},{"key":"1511_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-017-1302-z","volume":"17","author":"G Astatikie","year":"2017","unstructured":"Astatikie G, Limenih MA, Kebede M. Maternal and fetal outcomes of uterine rupture and factors associated with maternal death secondary to uterine rupture. BMC Pregnancy Childbirth. 2017;17:117.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1511_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5468\/ogs.2019.62.5.299","volume":"62","author":"J Takeda","year":"2019","unstructured":"Takeda J, Takeda S. Management of disseminated intravascular coagulation associated with placental abruption and measures to improve outcomes. Obstet Gynecol Sci. 2019;62:299\u2013306.","journal-title":"Obstet Gynecol Sci"},{"key":"1511_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-022-04807-8","volume":"22","author":"H Li","year":"2022","unstructured":"Li H, Nawsherwan, Fan C, Mubarik S, Nabi G, Ping YX. The trend in delayed childbearing and its potential consequences on pregnancy outcomes: a single center 9-years retrospective cohort study in Hubei, China. BMC Pregnancy Childbirth. 2022;22:514.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1511_CR17","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1210\/jc.2019-00315","volume":"104","author":"S Bhasin","year":"2019","unstructured":"Bhasin S, Kerr C, Oktay K, Racowsky C. The implications of reproductive aging for the health, vitality, and economic welfare of human societies. J Clin Endocrinol Metab. 2019;104:3821\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"1511_CR18","doi-asserted-by":"publisher","first-page":"100657","DOI":"10.1016\/j.eclinm.2020.100657","volume":"29-30","author":"E Bornstein","year":"2020","unstructured":"Bornstein E, Eliner Y, Chervenak FA, Gr\u00fcnebaum A. Concerning trends in maternal risk factors in the United States: 1989-2018. EClinicalMedicine. 2020;29-30:100657.","journal-title":"EClinicalMedicine"},{"key":"1511_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.15585\/mmwr.mm7117a1","volume":"71","author":"ND Ford","year":"2022","unstructured":"Ford ND, Cox S, Ko JY, Ouyang L, Romero L, Colarusso T, et al. Hypertensive disorders in pregnancy and mortality at delivery hospitalization - United States, 2017-2019. MMWR Morb Mortal Wkly Rep. 2022;71:585\u201391.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"1511_CR20","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1161\/HYP.0000000000000208","volume":"79","author":"VD Garovic","year":"2022","unstructured":"Garovic VD, Dechend R, Easterling T, Karumanchi SA, McMurtry Baird S, Magee LA, et al. Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American heart association. Hypertension. 2022;79:e21\u2013e41.","journal-title":"Hypertension"},{"key":"1511_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-9-8","volume":"9","author":"K Haram","year":"2009","unstructured":"Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A Review. BMC Pregnancy Childbirth. 2009;9:8.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1511_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fgene.2014.00187","volume":"5","author":"X Wang","year":"2014","unstructured":"Wang X. Firth logistic regression for rare variant association tests. Front Genet. 2014;5:187.","journal-title":"Front Genet"},{"key":"1511_CR23","doi-asserted-by":"crossref","unstructured":"Rao D, Chaudhari NK, Moore RM, Jim B. HELLP syndrome: a diagnostic conundrum with severe complications. BMJ Case Rep. 2016;2016:bcr2016216802.","DOI":"10.1136\/bcr-2016-216802"},{"key":"1511_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000369553","volume":"38","author":"JL Rojas-Arias","year":"2015","unstructured":"Rojas-Arias JL, Ortiz-L\u00f3pez LD, Ordu\u00f1a-Aparicio WJ, Quintero-Loaiza CA, Acu\u00f1a-Osorio E, Franco-Hern\u00e1ndez A, et al. Characterization of atypical preeclampsia. Fetal Diagn Ther. 2015;38:119\u201325.","journal-title":"Fetal Diagn Ther"},{"key":"1511_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4314\/ejhs.v26i2.12","volume":"26","author":"Y Berhan","year":"2016","unstructured":"Berhan Y. No hypertensive disorder of pregnancy; no preeclampsia-eclampsia; no gestational hypertension; no hellp syndrome. vascular disorder of pregnancy speaks for all. Ethiop J Health Sci. 2016;26:177\u201386.","journal-title":"Ethiop J Health Sci"},{"key":"1511_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ijgo.2008.09.014","volume":"104","author":"P Vigil-De Gracia","year":"2009","unstructured":"Vigil-De Gracia P. Maternal deaths due to eclampsia and HELLP syndrome. Int J Gynaecol Obstet. 2009;104:90\u201394.","journal-title":"Int J Gynaecol Obstet"},{"key":"1511_CR27","doi-asserted-by":"publisher","first-page":"e0263731","DOI":"10.1371\/journal.pone.0263731","volume":"17","author":"O Bazirete","year":"2022","unstructured":"Bazirete O, Nzayirambaho M, Umubyeyi A, Karangwa I, Evans M. Risk factors for postpartum haemorrhage in the Northern Province of Rwanda: a case control study. PLoS One. 2022;17:e0263731.","journal-title":"PLoS One"},{"key":"1511_CR28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/1471-0528.13098","volume":"122","author":"A Weeks","year":"2015","unstructured":"Weeks A. The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next? BJOG. 2015;122:202\u201310.","journal-title":"BJOG"},{"key":"1511_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ijgo.2014.08.023","volume":"128","author":"EA Rocha Filho","year":"2015","unstructured":"Rocha Filho EA, Costa ML, Cecatti JG, Parpinelli MA, Haddad SM, Pacagnella RC, et al. Severe maternal morbidity and near miss due to postpartum hemorrhage in a national multicenter surveillance study. Int J Gynaecol Obstet. 2015;128:131\u20136.","journal-title":"Int J Gynaecol Obstet"},{"key":"1511_CR30","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/aogs.14508","volume":"102","author":"HJ Baldwin","year":"2023","unstructured":"Baldwin HJ, Randall DA, Maher R, West SP, Torvaldsen S, Morris JM, et al. Interventional radiology in obstetric patients: a population-based record linkage study of use and outcomes. Acta Obstet Gynecol Scand. 2023;102:370\u20137.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1511_CR31","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00270-010-9864-4","volume":"33","author":"M Gonsalves","year":"2010","unstructured":"Gonsalves M, Belli A. The role of interventional radiology in obstetric hemorrhage. Cardiovasc Interv Radio. 2010;33:887\u201395.","journal-title":"Cardiovasc Interv Radio"},{"key":"1511_CR32","first-page":"111","volume":"22","author":"M Kawai","year":"2019","unstructured":"Kawai M, Harada M, Motoike Y, Koshikawa M, Ichikawa T, Watanabe E, et al. Impact of serum albumin levels on supratherapeutic PT-INR control and bleeding risk in atrial fibrillation patients on warfarin: a prospective cohort study. Int J Cardiol Heart Vasc. 2019;22:111\u20136.","journal-title":"Int J Cardiol Heart Vasc"},{"key":"1511_CR33","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.clinthera.2009.07.015","volume":"31","author":"AH Abdelhafiz","year":"2009","unstructured":"Abdelhafiz AH, Myint MP, Tayek JA, Wheeldon NM. Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: a secondary analysis. Clin Ther. 2009;31:1534\u20139.","journal-title":"Clin Ther"},{"key":"1511_CR34","doi-asserted-by":"publisher","first-page":"536","DOI":"10.26502\/fccm.92920296","volume":"6","author":"N Perel","year":"2022","unstructured":"Perel N, Taha L, Farkash R, Steinmetz Y, Shaheen F, Levi N, et al. Level of hypoalbuminemia as a prognostic factor in patients admitted to a tertiary care intensive coronary care unit. Cardiol Cardiovasc Med. 2022;6:536\u201341.","journal-title":"Cardiol Cardiovasc Med"},{"key":"1511_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jpen.1451","volume":"43","author":"PB Soeters","year":"2019","unstructured":"Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: pathogenesis and clinical significance. J Parenter Enter Nutr. 2019;43:181\u201393.","journal-title":"J Parenter Enter Nutr"},{"key":"1511_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/jgf2.281","volume":"21","author":"T Akaishi","year":"2020","unstructured":"Akaishi T, Yasaka K, Abe M, Fujii H, Watanabe M, Shirai T, et al. Protein-losing gastroenteropathy with severe hypoalbuminemia associated with Sj\u00f6gren\u2019s syndrome: a case report and review of the literature. J Gen Fam Med. 2020;21:24\u201328.","journal-title":"J Gen Fam Med"},{"key":"1511_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/01.SLA.0000055547.93484.87","volume":"237","author":"JL Vincent","year":"2003","unstructured":"Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237:319\u201334.","journal-title":"Ann Surg."}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01511-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01511-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01511-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:06:58Z","timestamp":1707091618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01511-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,22]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1511"],"URL":"https:\/\/doi.org\/10.1038\/s41440-023-01511-8","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,22]]},"assertion":[{"value":"29 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Boards of Tohoku University Graduate School of Medicine (approval number: 2022-1-441) and Tokyo Medical and Dental University (approval number: M2000-788). Written informed consent was waived by the review boards because the used data was anonymized and included no personal information that could identify the individuals. Approvals to use the anonymized data were obtained from all cooperated facilities. The study protocol and processes were released on the websites of Tokyo Medical and Dental University and Tohoku University. All process of this study were performed in accordance with the latest version of the Declaration of Helsinki as revised in 2013.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}